 Mutation
"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
| Descriptor ID |
D009154
|
| MeSH Number(s) |
G05.365.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 5 | 6 | | 1981 | 0 | 5 | 5 | | 1982 | 1 | 6 | 7 | | 1983 | 3 | 7 | 10 | | 1984 | 3 | 11 | 14 | | 1985 | 5 | 13 | 18 | | 1986 | 3 | 16 | 19 | | 1987 | 6 | 10 | 16 | | 1988 | 4 | 11 | 15 | | 1989 | 13 | 13 | 26 | | 1990 | 10 | 19 | 29 | | 1991 | 13 | 11 | 24 | | 1992 | 14 | 24 | 38 | | 1993 | 10 | 17 | 27 | | 1994 | 12 | 33 | 45 | | 1995 | 16 | 28 | 44 | | 1996 | 24 | 23 | 47 | | 1997 | 26 | 20 | 46 | | 1998 | 25 | 39 | 64 | | 1999 | 15 | 36 | 51 | | 2000 | 28 | 43 | 71 | | 2001 | 15 | 51 | 66 | | 2002 | 21 | 51 | 72 | | 2003 | 22 | 79 | 101 | | 2004 | 19 | 60 | 79 | | 2005 | 26 | 80 | 106 | | 2006 | 25 | 76 | 101 | | 2007 | 29 | 58 | 87 | | 2008 | 26 | 65 | 91 | | 2009 | 25 | 66 | 91 | | 2010 | 34 | 69 | 103 | | 2011 | 38 | 84 | 122 | | 2012 | 44 | 73 | 117 | | 2013 | 41 | 75 | 116 | | 2014 | 44 | 81 | 125 | | 2015 | 46 | 92 | 138 | | 2016 | 40 | 95 | 135 | | 2017 | 30 | 72 | 102 | | 2018 | 39 | 99 | 138 | | 2019 | 48 | 65 | 113 | | 2020 | 24 | 91 | 115 | | 2021 | 23 | 79 | 102 | | 2022 | 5 | 24 | 29 |
To return to the timeline, click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Carrasquel-Ursulaez W, Segura I, Díaz-Franulic I, Echeverría F, Lorenzo-Ceballos Y, Espinoza N, Rojas M, Garate JA, Perozo E, Alvarez O, Gonzalez-Nilo FD, Latorre R. Mechanism of voltage sensing in Ca2+- and voltage-activated K+ (BK) channels. Proc Natl Acad Sci U S A. 2022 Jun 21; 119(25):e2204620119.
-
Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Récher C, Yoon SS, Hosono N, Onozawa M, Chiba S, Kim HJ, Hasabou N, Lu Q, Tiu R, Levis MJ. Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial. Blood. 2022 Jun 09; 139(23):3366-3375.
-
Zou H, Pan T, Gao Y, Chen R, Li S, Guo J, Tian Z, Xu G, Xu J, Ma Y, Li Y. Pan-cancer assessment of mutational landscape in intrinsically disordered hotspots reveals potential driver genes. Nucleic Acids Res. 2022 05 20; 50(9):e49.
-
Keefer LA, White JR, Wood DE, Gerding KMR, Valkenburg KC, Riley D, Gault C, Papp E, Vollmer CM, Greer A, Hernandez J, McGregor PM, Zingone A, Ryan BM, Deak K, McCall SJ, Datto MB, Prescott JL, Thompson JF, Cerqueira GC, Jones S, Simmons JK, McElhinny A, Dickey J, Angiuoli SV, Diaz LA, Velculescu VE, Sausen M. Automated next-generation profiling of genomic alterations in human cancers. Nat Commun. 2022 May 20; 13(1):2830.
-
Park Y, Metzger BPH, Thornton JW. Epistatic drift causes gradual decay of predictability in protein evolution. Science. 2022 05 20; 376(6595):823-830.
-
Hosfield DJ, Weber S, Li NS, Suavage M, Joiner CF, Hancock GR, Sullivan EA, Ndukwe E, Han R, Cush S, Lainé M, Mader SC, Greene GL, Fanning SW. Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells. Elife. 2022 May 16; 11.
-
Sasani TA, Ashbrook DG, Beichman AC, Lu L, Palmer AA, Williams RW, Pritchard JK, Harris K. A natural mutator allele shapes mutation spectrum variation in mice. Nature. 2022 05; 605(7910):497-502.
-
Weinberg OK, Siddon A, Madanat YF, Gagan J, Arber DA, Dal Cin P, Narayanan D, Ouseph MM, Kurzer JH, Hasserjian RP. TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML. Blood Adv. 2022 05 10; 6(9):2847-2853.
-
Li S, Zeng W, Ni X, Zhou Y, Stackpole ML, Noor ZS, Yuan Z, Neal A, Memarzadeh S, Garon EB, Dubinett SM, Li W, Zhou XJ. cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution. Clin Cancer Res. 2022 May 02; 28(9):1841-1853.
-
Pirozzi F, Berkseth M, Shear R, Gonzalez L, Timms AE, Sulc J, Pao E, Oyama N, Forzano F, Conti V, Guerrini R, Doherty ES, Saitta SC, Lockwood CM, Pritchard CC, Dobyns WB, Novotny E, Wright JNN, Saneto RP, Friedman S, Hauptman J, Ojemann J, Kapur RP, Mirzaa GM. Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care. Brain. 2022 Apr 29; 145(3):925-938.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|